查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1918114

關節間隔物市場 - 2026-2031 年預測

Joint Spacer Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計關節間隔物市場將從 2025 年的 15.18 億美元成長到 2031 年的 21.57 億美元，複合年成長率為 6.03%。

全球關節間隔器市場預計在預測期內將保持穩定成長，這主要歸因於整形外科植入手術數量的增加以及假體關節感染（PJI）的持續挑戰。關節間隔器（無論是活動式或預製式）是一種載有抗生素的骨水泥裝置，旨在兩階段關節重建手術的兩個階段之間維持關節的臨時活動度和功能。初次膝關節、髖關節和肩關節關節重建手術數量的增加與PJI發病率的上升直接相關，從而導致重新置換手術中對可靠的間隔器系統有著持續的需求。

關鍵成長要素包括持續的產品創新，重點在於預製和移動式間隔器；擴大兩階段重新置換通訊協定的適應症；並將先進抗生素整合到間隔器設計中。製造商正優先提供即用型系統，這些系統具有標準化的尺寸、更高的機械穩定性以及最佳化的局部抗生素釋放曲線。這些改進滿足了外科醫生在處理複雜感染關節病例時對可重複結果的需求。

從地理上看，由於骨關節炎的高發病率、運動和肥胖相關關節損傷數量的增加，以及新一代間隔物技術監管核准的強勁進展，預計北美將在整個預測期內保持其市場主導地位。該地區受益於有利的醫保報銷政策和領先的整形外科製造商的大量研發投入，從而推動了先進技術植入的快速普及。

在生產環境中，成熟的現成系統繼續發揮核心作用：

  • Synicem™ 間隔器系列產品提供含抗生素的即用型產品，適用於髖關節、膝關節和肩關節翻修重新置換。這些裝置旨在維持關節間隙，促進感染控制，並在兩階段通訊協定中提供中等程度的軟組織張力支撐。
  • Spacer®-G 是一種廣泛使用的預製慶大霉素髖關節間隔器，採用不銹鋼芯加固，有多種頭部直徑（46-60 毫米）和柄長可供選擇，可在感染性重新置換置換術中提供一致的承重能力和可控的抗生素釋放。

競爭格局的特點是產品線持續擴張，並策略性地聚焦於感染控制解決方案。領先的製造商正投資於多孔塗層和奈米技術增強表面，以在適當情況下促進生物整合，同時保持其高劑量局部抗生素遞送的核心功能。併購和共同開發契約仍然是鞏固市場地位和加速推出下一代間隔物平台的常用策略。

儘管有許多有利因素，但由於其他感染控制方法的普及，包括單階段重新置換通訊協定和某些患者群體中不依賴間隔物的抗菌策略，市場仍面臨許多限制。這些替代方案可能會限制該產品在某些臨床場景和治療方法不同的地區得到應用。

總體而言，受初次關節重建數量穩步成長、假體周圍感染問題持續存在以及臨時植入解決方案技術不斷進步的推動，關節間隔器市場預計將持續擴張。北美在市場佔有率和創新速度方面繼續保持主導，Synicem™ 和 Spacer®-G 等成熟的現成系統在全球兩階段重新置換手術中保持著較高的臨床認可度。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 依類型分類的關節間隔物市場

  • 介紹
  • 水泥固定
  • 非水泥型

第6章 依關節類型分類的關節間隔物市場

  • 介紹
  • 膝關節
  • 髖關節
  • 肩關節
  • 其他

第7章 依最終使用者分類的關節間隔物市場

  • 介紹
  • 醫院
  • 門診手術中心
  • 其他

第8章 各地區關節間隔物市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章：競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Abbott
  • Zimmer Biomet
  • Johnson & Johnson
  • Stryker Corporation
  • Heraeus Holding
  • Enovis Corporation
  • Exactech, Inc.
  • Arthrex Inc.
  • B. Braun SE
  • Tecres SpA

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061615586

The joint spacer market is expected to grow at a 6.03% CAGR, achieving USD 2.157 billion in 2031 from USD 1.518 billion in 2025.

The global joint spacer market is projected to grow at a steady pace during the forecast period, driven primarily by the increasing volume of orthopedic implantation procedures and the persistent challenge of prosthetic joint infection (PJI). Joint spacers-whether articulating or prefabricated-are antibiotic-loaded, bone-cement devices designed to maintain temporary joint mobility and function between stages of two-stage revision arthroplasty. Rising rates of primary knee, hip, and shoulder replacements directly correlate with increased PJI incidence, creating sustained demand for reliable spacer systems in revision surgery.

Key growth drivers include continued product innovation focused on prefabricated and articulating spacers, expanding indications for two-stage revision protocols, and the integration of advanced antibiotics into spacer designs. Manufacturers are prioritizing ready-to-use systems that offer standardized sizing, improved mechanical stability, and optimized local antibiotic elution profiles. These enhancements address surgeon demand for reproducible outcomes while managing complex infected joint cases.

Geographically, North America is expected to maintain market dominance throughout the forecast period. Contributing factors include a high prevalence of osteoarthritis, elevated rates of sports- and obesity-related joint injuries, and a robust pipeline of regulatory approvals for next-generation spacer technologies. The region benefits from rapid adoption of technologically advanced implants, supported by favorable reimbursement frameworks and concentrated R&D investment from leading orthopedic manufacturers.

In the product landscape, established prefabricated systems continue to play a central role:

  • The Synicem(TM) spacer range provides ready-to-use, antibiotic-loaded options for hip, knee, and shoulder revisions. These devices are engineered to preserve articular space, facilitate infection control, and support soft-tissue tension during the interim period of two-stage protocols.
  • Spacer(R)-G remains a widely utilized prefabricated gentamicin-loaded hip spacer. Reinforced with a stainless-steel core and available in multiple head diameters (46-60 mm) and stem lengths, it delivers consistent load-bearing capacity and controlled antibiotic release in infected total hip arthroplasty revisions.

Competitive dynamics are characterized by ongoing portfolio expansion and strategic focus on infection-management solutions. Leading manufacturers are investing in porous-coated and nanotechnology-enhanced surfaces to promote biological integration where appropriate, while maintaining the core function of high-dose local antibiotic delivery. Mergers, acquisitions, and collaborative development agreements remain prevalent tactics to strengthen market positioning and accelerate the introduction of next-generation spacer platforms.

Despite favorable tailwinds, the market faces constraints from the availability of alternative infection-management approaches, including single-stage revision protocols and non-spacer-based antimicrobial strategies in select patient cohorts. These alternatives may temper adoption in certain clinical scenarios or geographic regions with differing treatment preferences.

Overall, the joint spacer segment is poised for sustained expansion, underpinned by the inexorable rise in primary joint replacement volumes, the unchanging burden of periprosthetic infection, and continuous technological refinement of temporary implant solutions. North America will continue to lead both in market share and innovation velocity, while established prefabricated systems such as Synicem(TM) and Spacer(R)-G retain strong clinical acceptance in two-stage revision pathways worldwide.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Joint Spacer Market Segmentation:

  • By Type
  • Cemented
  • Non-Cemented
  • By Joint Type
  • Knee Joint
  • Hip Joint
  • Shoulder Joint
  • Others
  • By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. JOINT SPACER MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Cemented
  • 5.3. Non-Cemented

6. JOINT SPACER MARKET BY JOINT TYPE

  • 6.1. Introduction
  • 6.2. Knee Joint
  • 6.3. Hip Joint
  • 6.4. Shoulder Joint
  • 6.5. Others

7. JOINT SPACER MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. JOINT SPACER MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott
  • 10.2. Zimmer Biomet
  • 10.3. Johnson & Johnson
  • 10.4. Stryker Corporation
  • 10.5. Heraeus Holding
  • 10.6. Enovis Corporation
  • 10.7. Exactech, Inc.
  • 10.8. Arthrex Inc.
  • 10.9. B. Braun SE
  • 10.10. Tecres S.p.A.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations